Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Major Science and Technology Special Project of China Twelfth-Five-Year Project | Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
EFFORT Further Extension Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 07, 2016
Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Major Science and Technology Special Project of China Twelfth-Five-Year Project | Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 07, 2014
Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Telbivudine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase IV
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 26, 2013
Lead Product(s) : Telbivudine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase IV
Sponsor : Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : New Discovery
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 06, 2012
Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : New Discovery
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Major Science & Tech Project China 11th Five-Year | Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 08, 2012
Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Major Science & Tech Project China 11th Five-Year | Novartis Pharmaceuticals Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 23, 2011
Lead Product(s) : Telbivudine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
